Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Scope of the Report:
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.
Nonetheless, this market is not big because the relatively high price of the needle-free injectors compared to the disposable injectors. Mergers and acquisitions usually happen amony needle-free injection devices producers. For example, Bioject has been purchased by Inovio.
Globally, the global production was 2927 K units in 2015, and it will reach 4587K units in 2021. The global production value was 299.39 million USD in 2015, and it is expected that the value will be 436.3 million USD in 2021, with9.14% annual compound growth.
The worldwide market for Needle-Free Injection Device is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Needle-Free Injection Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Zogenix
Inovio
Glide Pharma
Akra Dermojet
Crossject Medical Technology
Injex Pharma
Eternity Healthcare
Antares Pharma
Valeritas
Medical International Technologies
Penjet
PharmaJet
National Medical Products
Activa Brand Products
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Powder Injections
Liquid Injections
Depot or Projectile Injection
Market Segment by Applications, can be divided into
Drug Injection
Cosmetic Surgery Use
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Needle-Free Injection Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Needle-Free Injection Device, with price, sales, revenue and global market share of Needle-Free Injection Device in 2017 and 2018.
Chapter 3, the Needle-Free Injection Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Needle-Free Injection Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Needle-Free Injection Device market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Needle-Free Injection Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Scope of the Report:
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.
Nonetheless, this market is not big because the relatively high price of the needle-free injectors compared to the disposable injectors. Mergers and acquisitions usually happen amony needle-free injection devices producers. For example, Bioject has been purchased by Inovio.
Globally, the global production was 2927 K units in 2015, and it will reach 4587K units in 2021. The global production value was 299.39 million USD in 2015, and it is expected that the value will be 436.3 million USD in 2021, with9.14% annual compound growth.
The worldwide market for Needle-Free Injection Device is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Needle-Free Injection Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Zogenix
Inovio
Glide Pharma
Akra Dermojet
Crossject Medical Technology
Injex Pharma
Eternity Healthcare
Antares Pharma
Valeritas
Medical International Technologies
Penjet
PharmaJet
National Medical Products
Activa Brand Products
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Powder Injections
Liquid Injections
Depot or Projectile Injection
Market Segment by Applications, can be divided into
Drug Injection
Cosmetic Surgery Use
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Needle-Free Injection Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Needle-Free Injection Device, with price, sales, revenue and global market share of Needle-Free Injection Device in 2017 and 2018.
Chapter 3, the Needle-Free Injection Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Needle-Free Injection Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Needle-Free Injection Device market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Needle-Free Injection Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
